GW Pharma (GWPH) Posts Q1 Loss of 9c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Leerink Affirms GW Pharma (GWPH) at 'Outperform'; Focus Now on LGS Phase III Data
May 5, 2016 12:28 PM EDTLeerink affirms GW Pharma (Nasdaq: GWPH) at Outperform with a price target of $130 following Q1 results reported earlier.
Analyst Paul Matteis offered the following commentary: This morning GWPH reported F2Q16 EPS of £(0.06) versus our estimate of £(0.12) and specified timing of... More
